Clinical Trials

Andrew Ciupek, PhD, spoke with Healio about real-world barriers to clinical trial enrollment for patients with lung cancer in the United States.

Amneal Pharmaceuticals Inc. announced it has submitted a new drug application to the FDA for IPX203, an oral formulation of carbidopa/levodopa extended-release capsules for the treatment of Parkinson’s disease.

Vamorolone demonstrated efficacy and safety in the treatment of boys with Duchenne muscular dystrophy over a 24-week treatment period and may be safer than prednisone, according to a study published in JAMA Neurology.

Unequal distribution of trial sites nationwide has led to inequitable access to cutting-edge immunotherapies among Black patients with advanced multiple myeloma, according to research published in JAMA Network Open.

Psilocybin-assisted psychotherapy significantly reduced the number of heavy drinking days in those with alcohol use disorder compared with placebo and psychotherapy, results of a clinical trial show.

Fewer than half of breast cancer studies in the National Cancer Database reported Hispanic ethnicity and about one-third categorized race and ethnicity into mutually exclusive groups, according to study results.

When it comes to their approaches to work, Maya Birhiray, BS, and her father, Ruemu Birhiray, MD, have very different styles.

Biopharmaceutical company Cybin Inc. and its partner Clinilabs Drug Development Corp. announced they have been granted a Schedule I license to support a clinical trial for a psychedelic-based treatment to treat major depressive disorder.

Eicosapentaenoic acid at a dose of 4 g per day reduced effects of major depressive disorder in overweight individuals with elevated inflammatory markers better than placebo at 12 weeks, according to a recently published study.

Goals for organizations aiming to foster community engagement include commitment to building trust and encouraging clinical trial participation among underrepresented groups, a speaker said.